These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2147740)

  • 1. The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat.
    Trampus M; Ongini E
    Neuropharmacology; 1990 Oct; 29(10):889-93. PubMed ID: 2147740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine D1 receptor is involved in the regulation of REM sleep in the rat.
    Trampus M; Ferri N; Monopoli A; Ongini E
    Eur J Pharmacol; 1991 Mar; 194(2-3):189-94. PubMed ID: 2060599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat.
    Ongini E; Bonizzoni E; Ferri N; Milani S; Trampus M
    J Pharmacol Exp Ther; 1993 Aug; 266(2):726-31. PubMed ID: 8102647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-induced insomnia: opioid-dopamine interactions.
    Fratta W; Collu M; Martellotta MC; Pichiri M; Muntoni F; Gessa GL
    Eur J Pharmacol; 1987 Oct; 142(3):437-40. PubMed ID: 2892686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of REM sleep deprivation on the d-amphetamine-induced self-mutilating behavior.
    Lara-Lemus A; Pérez de la Mora M; Méndez-Franco J; Palomero-Rivero M; Drucker-Colín R
    Brain Res; 1997 Oct; 770(1-2):60-4. PubMed ID: 9372203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.
    Monti JM; Hawkins M; Jantos H; D'Angelo L; Fernández M
    Psychopharmacology (Berl); 1988; 95(3):395-400. PubMed ID: 3137628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on wakefulness-promoting effect of memantine in rats.
    Ishida T; Obara Y; Kamei C
    Behav Brain Res; 2010 Jan; 206(2):274-8. PubMed ID: 19781580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and behavioral effects of D1 dopamine antagonists.
    Barnett A; Iorio LC; McQuade R; Chipkin RE
    Adv Exp Med Biol; 1988; 235():137-44. PubMed ID: 2976247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat.
    Trampus M; Ferri N; Adami M; Ongini E
    Eur J Pharmacol; 1993 Apr; 235(1):83-7. PubMed ID: 8100197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.
    Koob GF; Le HT; Creese I
    Neurosci Lett; 1987 Aug; 79(3):315-20. PubMed ID: 2958724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation.
    Lima MM; Andersen ML; Reksidler AB; Silva A; Zager A; Zanata SM; Vital MA; Tufik S
    Behav Brain Res; 2008 Apr; 188(2):406-11. PubMed ID: 18201777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Fernández M
    Eur J Pharmacol; 1989 Oct; 169(1):61-6. PubMed ID: 2574689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of remoxipride, a dopamine D-2 antagonist antipsychotic, on sleep-waking patterns and EEG activity in rats and rabbits.
    Ongini E; Bo P; Dionisotti S; Trampus M; Savoldi F
    Psychopharmacology (Berl); 1992; 107(2-3):236-42. PubMed ID: 1352054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS; Starr MS
    Neuropharmacology; 1987 Jun; 26(6):613-9. PubMed ID: 2955244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra.
    Cruz CJ; Beckstead RM
    Brain Res; 1988 Aug; 457(1):29-43. PubMed ID: 2458801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
    Chipkin RE
    Pharmacol Biochem Behav; 1988 Jul; 30(3):683-6. PubMed ID: 2974995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol.
    Witkin JM; Goldberg SR; Katz JL
    Life Sci; 1989; 44(18):1285-91. PubMed ID: 2523996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.